Dockets management and analysis for modified risk tobacco product applications
Ended Awarded Last action
- Contract number
- 75F40124F19011
- Awardee
-
ICF Incorporated, L.L.C. UEI QHBLBNKKV4U3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $132,914
Award facts
- Contract value 100% obligated
- $132,914.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Labor Hours
- Place of performance
- Reston, VA 20190, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $132,914 |
About this award
ICF Incorporated, L.L.C., a Reston, Virginia-based consulting and technology services firm, was awarded a Blanket Purchase Agreement (BPA) call valued at $132,914 by the Food and Drug Administration (FDA) on August 12, 2024, for dockets management and analysis services related to Modified Risk Tobacco Product applications. The contract, which carries a labor-hours pricing structure and is scheduled for completion by September 26, 2026, will be performed in Reston, Virginia. This award represents a child task order under ICF's broader Multiple Award Schedule contract vehicle with the federal government.
The engagement supports the FDA's Center for Tobacco Products in managing and analyzing regulatory dockets associated with manufacturers' applications seeking FDA authorization to market tobacco products with modified risk claims. This specialized administrative and analytical work is essential to the FDA's evaluation process for these complex regulatory submissions. The contract carries no small business set-aside designation, consistent with ICF's status as a large, established federal contractor with a substantial portfolio of work across civilian agencies, including extensive experience supporting health, regulatory analysis, and public health initiatives through its existing blanket purchase agreements and indefinite delivery vehicles.
Quick answers
Who was awarded contract 75F40124F19011?
75F40124F19011 was awarded to ICF Incorporated, L.L.C. by Food and Drug Administration (Department of Health and Human Services) on August 12, 2024.
How much is contract 75F40124F19011 worth?
The government has obligated $132,914 on 75F40124F19011.
Is contract 75F40124F19011 an order under another contract?
Yes. 75F40124F19011 is a BPA call under GS00F010CA-75F40120A00041, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40124F19011 competed?
The extent of competition for 75F40124F19011 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award